Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSTP1 | P09211 | 1/20 | 0.42 |
| ▸ | ESR1 | P03372 | 1/20 | 0.42 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.42 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.41 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.40 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.38 |
| ▸ | CYP11B1 | P15538 | 3/20 | 0.38 |
| ▸ | CYP11B2 | P19099 | 3/20 | 0.38 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.38 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.37 |
| ▸ | CA1 | P00915 | 2/20 | 0.37 |
| ▸ | CA2 | P00918 | 2/20 | 0.37 |
| ▸ | CA9 | Q16790 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.36 |
| ▸ | NPC1 | O15118 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | RAB9A | P51151 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2459864 | 0.96 | ESR1 (0.38) | GSTP1ESR1ESR2ALOX5HSD17B1 | |
| SCHEMBL292658 | 0.86 | ALDH1A1 (0.34) | GSTP1ESR1ESR2HSD17B1HSD17B2 | |
| SCHEMBL1719526 | 0.86 | GSTP1 (0.44) | GSTP1ESR1ESR2ALOX5HSD17B1 | |
| SCHEMBL4216130 | 0.85 | ESR1 (0.38) | GSTP1ESR1ESR2ALOX5HSD17B1 | |
| SCHEMBL2152944 | 0.84 | TDP1 (0.44) | GSTP1CYP1A2SMN1; SMN2ALDH1A1KDM4E | |
| SCHEMBL3089094 | 0.79 | HSD17B1 (0.50) | GSTP1ESR1ESR2ALOX5HSD17B1 | |
| SCHEMBL4718441 | 0.74 | CYP3A4 (0.33) | CYP1A2SMN1; SMN2ALDH1A1KDM4ENPC1 | |
| SCHEMBL328771 | 0.74 | CYP2A6 (0.43) | GSTP1ESR1ESR2CYP1A2SMN1; SMN2 | |
| SCHEMBL29104462 | 0.73 | HSD17B1 (0.44) | GSTP1ESR1ESR2ALOX5HSD17B1 | |
| SCHEMBL160792 | 0.73 | GSTP1 (0.42) | GSTP1ESR1ESR2ALOX5HSD17B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160240782-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICE | MERCK PATENT GMBH (DE) | 2016-08-18 | — | — | US | claimed |
| EP-2307520-B1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES | MERCK PATENT GMBH (DE) | 2015-11-11 | — | — | EP | claimed |
| US-9066410-B2 | Organic electronic device | MERCK PATENT GMBH (DE) | 2015-06-23 | — | — | US | claimed |
| US-8361638-B2 | Fluorine derivatives for organic electroluminescence devices | MERCK PATENT GMBH (DE) | 2013-01-29 | — | — | US | claimed |
| EP-2260023-B1 | FLUORENE DERIVATIVES FOR ORGANIC ELECTROLUMINESCENCE DEVICES | MERCK PATENT GMBH (DE) | 2012-04-25 | — | — | EP | claimed |
| JP-2011528324-A | — | — | 2011-11-17 | — | — | JP | claimed |
| US-20110140043-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICE | MERCK PATENT GMBH (DE) | 2011-06-16 | — | — | US | claimed |
| EP-2307520-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES | Merck Patent GmbH (DE) | 2011-04-13 | — | — | EP | claimed |
| US-20110037027-A1 | FLUORINE DERIVATIVES FOR ORGANIC ELECTROLUMINESCENCE DEVICES | MERCK PATENT GMBH (DE) | 2011-02-17 | — | — | US | claimed |
| EP-2260023-A1 | FLUORINE DERIVATIVES FOR ORGANIC ELECTROLUMINESCENCE DEVICES | Merck Patent GmbH (DE) | 2010-12-15 | — | — | EP | claimed |
| WO-2010094378-A1 | ORGANIC ELECTRONIC DEVICE | MERCK PATENT GMBH (DE) | 2010-08-26 | — | — | WO | claimed |
| WO-2010006680-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES | MERCK PATENT GMBH (DE) | 2010-01-21 | — | — | WO | claimed |
| WO-2009124627-A1 | FLUORINE DERIVATIVES FOR ORGANIC ELECTROLUMINESCENCE DEVICES | MERCK PATENT GMBH (DE) | 2009-10-15 | — | — | WO | claimed |
| EP-3211058-B1 | NEW MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2023-08-23 | — | — | EP | disclosed |
| WO-2023117835-A1 | ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2023-06-29 | — | — | WO | disclosed |
| EP-3211058-A1 | NEW MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | Merck Patent GmbH (DE) | 2017-08-30 | — | — | EP | disclosed |
| EP-2038370-A1 | NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | Merck Patent GmbH (DE) | 2009-03-25 | — | — | EP | disclosed |
| WO-2008145239-A2 | BENZANTHRACENE DERIVATIVES FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2008-12-04 | — | — | WO | disclosed |
| US-20080193797-A1 | Novel Materials for Organic Electroluminescent Devices | MERCK PATENT GMBH (DE) | 2008-08-14 | — | — | US | disclosed |
| WO-2008006449-A1 | NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2008-01-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080193797-A1 | Novel Materials for Organic Electroluminescent Devices | SLC40A1, SLC67A1, SLC29A1 | GSTP1 1764/4885ESR1 493/4885ESR2 677/4885 |
| US-20110140043-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICE | L1CAM, SLCO4C1, GJA1 | GSTP1 2452/4885ESR1 79/4885ESR2 159/4885 |
| US-20160240782-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICE | L1CAM, SLCO4C1, GJA1 | GSTP1 2452/4885ESR1 79/4885ESR2 159/4885 |
| US-20110037027-A1 | FLUORINE DERIVATIVES FOR ORGANIC ELECTROLUMINESCENCE DEVICES | SLCO4C1, CTCF, AFF2 | GSTP1 2603/4885ESR1 36/4885ESR2 198/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.